As CD8+ T lymphocytes were the predominant cells that infiltrated tumors after combined immunotherapy, we tested their systemic activation by an ELISPOT assay detecting the IFN-γ production in mononuclear cells isolated from spleens of non-tumor-bearing mice. This evidence concerns the gene IFNG and neoplasm.